Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The anti-tumor effects of PLX-4720 correlate with the blockade of MAPK pathway in those cells harboring the V600E mutation
Meisoindigo has been a routine therapeutic agent in the clinical treatment of chronic myelogenous leukemia (CML) in China since the 1980s
MK 5172 potassium salt
the NHC:A base pair led to the observed G to A (G:NHC:A) or C to U (C:G:NHC:A:U) mutations
InChi: InChI=1S/C16H17ClN2OS/c17-12-3-1-2-11-8-14(21-15(11)12)16(20)18-13-9-19-6-4-10(13)5-7-19/h1-3
c-di-AMP sodium(x) lic acid sodium salt The anti-tumor effects of PLX-4720c di AMP (Cyclic diadenylate) sodium is a STING agonist, which binds to the transmembrane protein STING thereby activating the TBK3 IRF3 signaling pathway, subsequently triggering the production of type I IFN and TNF. c di AMP sodium is also a bacterial second messenger, which regulates cell growth, survival, and virulence, primarily within Gram positive bacteria, and also regulates host immune response. c di AMP sodium acts as a potent mucosal